Immunopathology of TB: Studying the role of the lymph nodes in the TB spectrum.
Researchers working on a novel study of the lymph nodes of humans discuss this complex project which is studying lymph node immunology, and the role of these organs in the progression to TB disease with a Wellcome Leap grant.
Professor Mark Hatherill addresses United Nations High-level Meeting on Tuberculosis
SEPTEMBER 2023: Prof Mark Hatherill, addressed the UN High-level Meeting on Tuberculosis, calling for a quantum jump in TB vaccine research and development (R&D) funding, to deliver the transformative tools needed to end the TB pandemic.
Titan Vaccine Research Project
Dr Munyaradzi Musvosvi speaks about the Titan Vaccine Research Project which will allow the selection of the most promising TB vaccine candidates.
Phase 1b/2a clinical trial in adults of novel TB vaccine candidate MTBVAC shows promising results.
Findings from the IAVI A-050 study, published in Lancet Global Health, demonstrate that vaccination with MTBVAC caused similar or stronger immune responses compared to the BCG vaccine in adults, of MTBVAC were as safe as BCG.
Narrative history of the South African Tuberculosis Vaccine Initiative
A narrative history of the South African Tuberculosis Vaccine Initiative as told through the voices of the many people who were involved in setting up and sustaining the organisation from 2001 to the present.
News from the South African Tuberculosis Vaccine Initiative.
Latest Research: Advancing national preparedness for the introduction of novel tuberculosis vaccines in South Africa: policy, evidence, and system readiness insights from a national workshop
Assoc Professor Angelique Luabeya has co-authored: Advancing national preparedness for introduction of novel tuberculosis vaccines in South Africa: policy, evidence, & system readiness insights from a national workshop appearing the Vaccine
Read more
Professor Tom Scriba named finalist for Harry Oppenheimer Fellowship Award
We are proud to announce that Professor Thomas Scriba is a finalist for the Harry Oppenheimer Fellowship Award.
Read more
African delegates witness cutting-edge TB research at UCT
A delegation of African parliamentarians and global health representatives visited the UCT Lung Institute and the South African Tuberculosis Vaccine Initiative (SATVI) on Friday, 15 May 2026.
Read more
A year in review: SATVI's 2025 Annual Report
SATVI has published its 2025 Annual Report, offering a comprehensive look at the year's research progress, clinical trial milestones and partnerships shaping the global TB vaccine pipeline. Download the full report below to read more.
Read more
Vacancies
No vacancies found
Previous highlights
Professor Mark Hatherill addresses United Nations High-level Meeting on Tuberculosis
SEPTEMBER 2023: Prof Mark Hatherill, addressed the UN High-level Meeting on Tuberculosis, calling for a quantum jump in TB vaccine research and development (R&D) funding, to deliver the transformative tools needed to end the TB pandemic.
Read more
Phase 1b/2a clinical trial in adults of novel TB vaccine candidate MTBVAC shows promising results.
Findings from the IAVI A-050 study, published in Lancet Global Health, demonstrate that vaccination with MTBVAC caused similar or stronger immune responses compared to the BCG vaccine in adults, of MTBVAC were as safe as BCG.
Read more
Upcoming Events
No upcoming events.